drugset / Trial / NCT01635738

Probiotics and Allergic Diseases

NCT01635738 ↗

RandomizedParallel-groupTriple-blindSupportive care

Summary

Many studies had demonstrated that probiotics could be applied in the prevention and adjuvant treatment for allergic diseases. In this study, we investigate the effects of Lactobacillus paracasei GMNL-133(LP), Lactobacillus fermentum GM-090 (LF), and Lactobacillus paracasei GMNL-133(LP) with Lactobacillus fermentum GM-090 (LF) combination products used for adjuvant treatment of atopic dermatitis and asthma.

Timeline

Start
2011-12
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject LF GM-090 Unknown 2e+09 cells Oral
Subject LP GMNL-133 Unknown 2e+09 cells Oral

Indications